Novo Nordisk
NVO
431 hedge funds and large institutions have $6.47B invested in Novo Nordisk in 2013 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 181 increasing their positions, 122 reducing their positions, and 41 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 122
45% more funds holding in top 10
Funds holding in top 10: 11 → 16 (+5)
27% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 41
18% more call options, than puts
Call options by funds: $39M | Put options by funds: $33M
1% more funds holding
Funds holding: 425 → 431 (+6)
3% more capital invested
Capital invested by funds: $6.26B → $6.47B (+$210M)
1.17% less ownership
Funds ownership: 83.35% → 82.19% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$143M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$54.4M |
| 3 |
Lazard Asset Management
New York
|
+$42.1M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$27.6M |
| 5 |
Renaissance Technologies
New York
|
+$22.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$205M |
| 2 |
Jennison Associates
New York
|
-$76.1M |
| 3 |
OH
Orbis Holdings
Hamilton,
Bermuda
|
-$68.2M |
| 4 |
O
OppenheimerFunds
New York
|
-$61.1M |
| 5 |
JP Morgan Chase
New York
|
-$29.9M |
NVO Hedge Fund Activity: Q4 2013 in Review
431 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2013, worth a combined $6.47B — up 3.4% from $6.26B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new NVO positions and 41 closed out — a net gain of 11 holders — while 181 added to existing stakes and 122 trimmed.
The largest buyer was WCM Investment Management, adding an estimated $143M. The largest seller was Ameriprise, cutting an estimated $205M.
- 431 institutional investors held Novo Nordisk (NVO) as of Q4 2013, up from 425 in Q3 2013.
- Funds reported $6.47B of Novo Nordisk stock for Q4 2013, up 3.4% quarter-over-quarter.
- 52 funds opened new Novo Nordisk positions in Q4 2013 and 41 closed out, a net change of +11 holders.
- The largest Novo Nordisk buyer in Q4 2013 was WCM Investment Management, an estimated $143M added.
- The largest Novo Nordisk seller in Q4 2013 was Ameriprise, an estimated $205M sold.
Based on aggregated 13F filings for Q4 2013.